Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy

Filippo Lagi,Sasha Trevisan,Matteo Piccica,Lucia Graziani,Gregorio Basile,Jessica Mencarini,Beatrice Borchi,Lorenzo Menicacci,Micol Vaudo,Valentina Scotti,Alessia Fabbri,Giulia Bandini, Camilla Tozzetti,Andrea Berni,Noemi Aiezza,Giulia Pestelli, Valerio Turchi,Alberto Moggi Pignone,Loredana Poggesi,Carlo Nozzoli

International Journal of Infectious Diseases（2021）

引用 9|浏览8

暂无评分

摘要

•Alternative point-of-care test may help in suspected COVID-19 case classification.•FebriDx differentiates viral from bacterial acute respiratory infection.•FebriDx had a good concordance and high NPV compared to rt-PCR.•FebriDx could be a reliable rule out test for SARS-CoV-2 in high prevalence setting.

查看译文

关键词

COVID-19,FebriDx,Point-of-care,Italy,Accuracy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要